Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 65162-373

9 FDA label images from Amneal Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 65162-373). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Oxybutynin Chloride Extended Release Tablets Usp 1)

Structural Formula (Oxybutynin Chloride Extended Release Tablets Usp 1)
Chemical structure diagram of oxybutynin chloride showing its molecular components including a cyclohexyl group, phenyl group, an ester linkage, ethynyl group, and diethylamino functional group with hydrochloride.*
FDA Label Image

Figure 1 (Oxybutynin Chloride Extended Release Tablets Usp 2)

Figure 1 (Oxybutynin Chloride Extended Release Tablets Usp 2)
A pharmacokinetic line graph comparing mean plasma R-oxybutynin concentration (ng/mL) over 24 hours for two dosing regimens: Oxybutynin Chloride extended-release 10 mg once daily (QD) and oxybutynin 5 mg three times daily (TID). The x-axis shows time in hours, and the y-axis shows drug concentration, with error bars indicating variability at each time point.*
FDA Label Image

Figure 2 (Oxybutynin Chloride Extended Release Tablets Usp 3)

Figure 2 (Oxybutynin Chloride Extended Release Tablets Usp 3)
A line graph showing mean R-oxybutynin plasma concentration (ng/mL) over time (hours). The x-axis represents time in hours (0 to 24), and the y-axis shows plasma concentration from 0.0 to 2.0 ng/mL. Data points with error bars indicate variability at each time point over a 24-hour period, with concentrations roughly stable around 0.5 to 0.7 ng/mL.*
FDA Label Image

Study 1 (Oxybutynin Chloride Extended Release Tablets Usp 4)

Study 1 (Oxybutynin Chloride Extended Release Tablets Usp 4)
A horizontal error bar chart comparing Oxybutynin Chloride with Placebo. The chart shows data points with error bars centered around -20 for Oxybutynin Chloride and near 0 for Placebo, with a horizontal axis ranging from -40 to 40.*
FDA Label Image

Study 2 (Oxybutynin Chloride Extended Release Tablets Usp 5)

Study 2 (Oxybutynin Chloride Extended Release Tablets Usp 5)
A horizontal error bar plot comparing 'Oxybutynin Chloride' and 'oxybutynin', showing central points with error bars extending approximately from -40 to 0 on the x-axis, which ranges from -40 to 40. The y-axis labels the two compounds, and vertical lines are marked at positions -20, 0, and 20 on the x-axis.*
FDA Label Image

Study 3 (Oxybutynin Chloride Extended Release Tablets Usp 6)

Study 3 (Oxybutynin Chloride Extended Release Tablets Usp 6)
A horizontal error bar chart comparing two substances labeled Oxybutynin Chloride and oxybutynin, shown on a numerical axis ranging approximately from -40 to 40, with error bars extending around their respective values near -20 and slightly above -20 on the axis. The chart visually represents variability or confidence intervals for these two substances.*
FDA Label Image

5mg 30ct Label (Oxybutynin Chloride Extended Release Tablets Usp 7)

5mg 30ct Label (Oxybutynin Chloride Extended Release Tablets Usp 7)
Label for Oxybutynin Chloride Extended-Release Tablets, USP 5 mg, oral tablets distributed by Amneal Pharmaceuticals LLC. The label shows a 30-tablet package with dosing information referring to the package insert. The label includes storage instructions, a partial tablet image, and the NDC number 65162-371-03.*
FDA Label Image

10mg 30ct Label (Oxybutynin Chloride Extended Release Tablets Usp 8)

10mg 30ct Label (Oxybutynin Chloride Extended Release Tablets Usp 8)
Label for Oxybutynin Chloride Extended-Release Tablets USP, 10 mg strength, distributed by Amneal Pharmaceuticals LLC. The label indicates the product is for prescription use only, contains 30 tablets, and includes storage instructions and dosage formulation details.*
FDA Label Image

15mg 30ct Label (Oxybutynin Chloride Extended Release Tablets Usp 9)

15mg 30ct Label (Oxybutynin Chloride Extended Release Tablets Usp 9)
Label for Oxybutynin Chloride Extended-Release Tablets USP 15 mg by Amneal Pharmaceuticals LLC. The label shows a single tablet image, states the product is Rx only, and contains 30 tablets. Storage conditions and dosage instructions refer to the package insert. Includes an NDC number and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.